O'Shaughnessy Asset Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-7,894
Closed -$332K – 2834
2025
Q4
$332K Buy
7,894
+576
+8% +$23.2K ﹤0.01% 1717
2025
Q3
$251K Buy
+7,318
New +$210K ﹤0.01% 1841
2021
Q4
– Sell
-185
Closed -$9K – 2444
2021
Q3
$9K Sell
185
-3,945
-96% -$172K ﹤0.01% 2200
2021
Q2
$165K Sell
4,130
-4,410
-52% -$189K ﹤0.01% 1118
2021
Q1
$459K Buy
8,540
+256
+3% +$14.7K 0.01% 639
2020
Q4
$405K Buy
+8,284
New +$384K 0.01% 581

Other funds holding VCYT

O'Shaughnessy Asset Management's VCYT Position: Q1 2026 in Review

O'Shaughnessy Asset Management sold out of Veracyte (VCYT) in Q1 2026, closing a stake of 7,894 shares — an estimated $332K sold.

O'Shaughnessy Asset Management first reported a position in VCYT in Q4 2020 and held it in 6 quarters. The position peaked at $459K in Q1 2021. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • O'Shaughnessy Asset Management reported no remaining Veracyte position as of Q1 2026 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 7,894 Veracyte shares in Q1 2026, an estimated $332K.
  • O'Shaughnessy Asset Management first reported a position in Veracyte in Q4 2020 and held it in 6 quarters.
  • O'Shaughnessy Asset Management's Veracyte position peaked at $459K in Q1 2021.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q1 2026, filed 13 May 2026.